Prognostic value of myocardial ischemia and necrosis in depressed left ventricular function: A multicenter stress cardiac magnetic resonance registry;Valor pronóstico de la isquemia miocárdica y la necrosis en pacientes con la función ventricular izquierda deprimida: un registro multicéntrico con resonancia magnética cardiaca de estrés

Revista Espanola de Cardiologia

Volumn 67, Issue 9, 2014, Pages 693-700

  Husser, Oliver ^a,b   Monmeneu, Jose V ^c   Bonanad, Clara ^a   Lopez Lereu, Maria P ^c   Nuñez, Julio ^a   Bosch, Maria J ^d   Garcia, Carlos ^e   Sanchis, Juan ^a   Chorro, Francisco J ^a   Bodi, Vicente ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Hospital General Universitario Avda   (Spain)

^d HOSPITAL DE LA PLANA   (Spain)

^e HOSPITAL GENERAL DE CASTELLÓN   (Spain)

Author keywords

Depressed left ventricular function; Dipyridamole; Prognosis; Stress cardiac magnetic resonance imaging

Indexed keywords

DIPYRIDAMOLE;

ARTICLE; DISEASE REGISTRY; EXERCISE TEST; HEART DEATH; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PERFUSION; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE; PROGNOSIS; AGED; CARDIAC IMAGING; CARDIAC MUSCLE; CLINICAL TRIAL; COMPLICATION; FEMALE; MALE; MULTICENTER STUDY; MYOCARDIAL ISCHEMIA; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; REGISTER;

AGED; CARDIAC IMAGING TECHNIQUES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NECROSIS; PROGNOSIS; REGISTRIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84906936423     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2014.01.014     Document Type: Article

References (33)

1. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, and K. Dickstein et al. ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
2. W.C. Levy, D. Mozaffarian, D.T. Linker, S.C. Sutradhar, S.D. Anker, and A.B. Cropp et al. The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
3. L.J. Shaw, D.S. Berman, D.J. Maron, G.B. Mancini, S.W. Hayes, and P.M. Hartigan et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Circulation 117 2008 1283 1291
4. V. Bodi, J. Sanchis, J. Nunez, L. Mainar, M.P. Lopez-Lereu, and J.V. Monmeneu et al. Prognostic value of a comprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction JACC Cardiovasc Imaging 2 2009 835 842
5. V. Bodi, O. Husser, J. Sanchis, J. Núñez, J.V. Monmeneu, and M.P. López-Lereu et al. Prognostic implications of dipyridamole cardiac MR imaging: a prospective multicenter registry Radiology 262 2012 91 100
6. V. Bodi, J. Sanchis, M.P. Lopez-Lereu, J. Nunez, L. Mainar, and J.V. Monmeneu et al. Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease J Am Coll Cardiol 50 2007 1174 1179
7. K. Steel, R. Broderick, V. Gandla, E. Larose, F. Resnic, and M. Jerosch-Herold et al. Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease Circulation 120 2009 1390 1400
8. D. Buckert, P. Dewes, T. Walcher, W. Rottbauer, and P. Bernhardt Intermediate-term prognostic value of reversible perfusion deficit diagnosed by adenosine CMR: a prospective follow-up study in a consecutive patient population JACC Cardiovasc Imaging 6 2013 56 63
9. A. Schuster, G. Morton, A. Chiribiri, D. Perera, J.L. Vanoverschelde, and E. Nagel Imaging in the management of ischemic cardiomyopathy: special focus on magnetic resonance J Am Coll Cardiol 59 2012 359 370
10. P. Chareonthaitawee, B.J. Gersh, and J.A. Panza Is viability imaging still relevant in 2012? JACC Cardiovasc Imaging 5 2012 550 558
11. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, and P.A. Pellikka et al. Recommendations for chamber quantification Eur J Echocardiogr 7 2006 79 108
12. M.D. Cerqueira, N.J. Weissman, V. Dilsizian, A.K. Jacobs, S. Kaul, and W.K. Laskey et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 2002 539 542
13. A.J. Taylor, N. Al-Saadi, H. Abdel-Aty, J. Schulz-Menger, D.R. Messroghli, and M.G. Friedrich Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging Circulation 109 2004 2080 2085
14. R.J. Kim, E. Wu, A. Rafael, E.L. Chen, M.A. Parker, and O. Simonetti et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
15. V. Bodi, J. Sanchis, M.P. Lopez-Lereu, J. Nunez, L. Mainar, and J.V. Monmeneu et al. Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischaemic cascade Heart 95 2009 49 55
16. V. Bodí, O. Husser, J. Sanchis, J. Núñez, M.P. López-Lereu, and J.V. Monmeneu et al. Contractile reserve and extent of transmural necrosis in the setting of myocardial stunning: comparison at cardiac MR imaging Radiology 255 2010 755 763
17. J.V. Monmeneu, V. Bodí, M.P. López-Lereu, J. Sanchis, J. Núñez, and F. Chaustre et al. Análisis mediante resonancia magnética cardiaca del miocardio salvado tras infarto. Predictores e influencia en el remodelado adverso ventricular Rev Esp Cardiol 65 2012 634 641
18. J.J. Bax, D. Poldermans, A. Elhendy, J.H. Cornel, E. Boersma, and R. Rambaldi et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography J Am Coll Cardiol 34 1999 163 169
19. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195
20. R.C. Cury, C.A. Cattani, L.A. Gabure, D.J. Racy, J.M. De Gois, and U. Siebert et al. Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease Radiology 240 2006 39 45
21. G. Pilz, A. Jeske, M. Klos, E. Ali, B. Hoefling, and R. Scheck et al. Prognostic value of normal adenosine-stress cardiac magnetic resonance imaging Am J Cardiol 101 2008 1408 1412
22. G. Morton, A. Schuster, D. Perera, and E. Nagel Cardiac magnetic resonance imaging to guide complex revascularization in stable coronary artery disease Eur Heart J 31 2010 2209 2215
23. P.A. Tonino, B. De Bruyne, N.H. Pijls, U. Siebert, F. Ikeno, and M. Van't Veer et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention N Engl J Med 360 2009 213 224
24. R. Hachamovitch, A. Rozanski, L.J. Shaw, G.W. Stone, L.E. Thomson, and J.D. Friedman et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy Eur Heart J 32 2011 1012 1024
25. O. Buckley, and M. Di Carli Predicting benefit from revascularization in patients with ischemic heart failure: imaging of myocardial ischemia and viability Circulation 123 2011 444 450
26. V. Rizzello, D. Poldermans, A.F. Schinkel, E. Biagini, E. Boersma, and A. Elhendy et al. Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation Heart 92 2006 239 244
27. A. Pasquet, A. Robert, A.M. D'Hondt, R. Dion, J.A. Melin, and J.L. Vanoverschelde Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction Circulation 100 1999 141 148
28. J. Romero, X. Xue, W. Gonzalez, and M.J. Garcia CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials JACC Cardiovasc Imaging 5 2012 494 508
29. V. Bodí, J. Sanchis, M.P. Lopez-Lereu, J. Nunez, L. Mainar, and M. Pellicer et al. Evolution of 5 cardiovascular magnetic resonance-derived viability indexes after reperfused myocardial infarction Am Heart J 153 2007 649 655
30. P. Merlos, M.P. López-Lereu, J.V. Monmeneu, J. Sanchis, J. Núñez, and C. Bonanad et al. Valor pronóstico a largo plazo del análisis completo de los índices de resonancia magnética cardiaca tras un infarto de miocardio con elevación del segmento ST Rev Esp Cardiol 66 2013 613 622
31. D.H. Kwon, C.M. Halley, T.P. Carrigan, V. Zysek, Z.B. Popovic, and R. Setser et al. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study JACC Cardiovasc Imaging 2 2009 34 44
32. E.J. Velazquez, K.L. Lee, M.A. Deja, A. Jain, G. Sopko, A. Marchenko STICH Investigators Coronary-artery bypass surgery in patients with left ventricular dysfunction N Engl J Med 364 2011 1607 1616
33. R.O. Bonow, G. Maurer, K.L. Lee, T.A. Holly, P.F. Binkley, and P. Desvigne-Nickens et al. Myocardial viability and survival in ischemic left ventricular dysfunction N Engl J Med 364 2011 1617 1625